Dow Corning's Silicone Tubing Reduces Contamination Risks for Pharmaceutical Applications

Dow Corning Pharma Fabricated Tubing Assemblies (FTAs) help reduce the risk of contamination in biopharmaceutical and pharmaceutical processing. They also streamline production and reduce labor, helping drug manufacturers focus on what they do best: produce life-saving pharmaceuticals.

The tubing assemblies are produced at Dow Corning’s dedicated, FDA-registered Healthcare Industries Materials Site. Dow Corning controls each part of the supply chain and process, from synthesizing the silicone raw materials to formulating the elastomers, to extruding and fabricating the components and delivering the final assemblies.

Drug manufacturers have traditionally built tubing assemblies in-house by cutting silicone tubing to size and connecting it to plastic wyes, tees and other components. This process is cumbersome, labor intensive, and dilutes focus from drug production. To increase efficiency, Dow Corning Pharma FTAs come ready to use, molded as a single unit. The single-use convenience of the Pharma FTAs reduces the risk of contamination and minimizes the need for cleaning, thus lowering labor costs.

Pharma FTAs can be made from 50, 65, or 80-durometer silicone tubing or an additional option, Dow Corning® Pharma Advanced Pump Tubing (APT). APT is made from a special 50-durometer elastomer which allows the tubing to have approximately four to six times longer life in peristaltic pumps compared to standard 50-durometer tubing. Customized assemblies are available in a range of configurations including wyes, tees, cross-connections, reducers, stoppers and other non-silicone components such as filters, connectors, pinch clamps, and valves.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dow Corning. (2019, February 10). Dow Corning's Silicone Tubing Reduces Contamination Risks for Pharmaceutical Applications. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=15377.

  • MLA

    Dow Corning. "Dow Corning's Silicone Tubing Reduces Contamination Risks for Pharmaceutical Applications". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=15377>.

  • Chicago

    Dow Corning. "Dow Corning's Silicone Tubing Reduces Contamination Risks for Pharmaceutical Applications". AZoM. https://www.azom.com/news.aspx?newsID=15377. (accessed November 21, 2024).

  • Harvard

    Dow Corning. 2019. Dow Corning's Silicone Tubing Reduces Contamination Risks for Pharmaceutical Applications. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=15377.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.